Home »
News & Insights »
China IPR News »
【Other】Clarify the boundaries between patent protection of drugs and legal listing of generic drugs—Analysis of administrative adjudication of drug patent infringement dispute between Bayer company and CN company
【Other】Clarify the boundaries between patent protection of drugs and legal listing of generic drugs—Analysis of administrative adjudication of drug patent infringement dispute between Bayer company and CN company